• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Seattle Genetics Inc

+ Add to Watchlist

SGEN:US

37.4000 USD 1.0700 2.95%

As of 20:10:00 ET on 07/11/2014.

Company Profile for Seattle Genetics Inc (SGEN)

Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.

Contact Information

Seattle Genetics Inc

21823 30th Drive SE
Bothell, WA 98021
United States
Phone: 1-425-527-4000
Fax: 1-425-527-4001

Key Executives for Seattle Genetics Inc (SGEN)

Clay B SiegallChairman/Pres/CEO/Co-FounderTodd E SimpsonChief Financial Officer
Eric L DobmeierCOO/SecretaryJonathan DrachmanExec VP:Research & Dev
Vaughn B HimesExec VP:Technical OpsChris BoernerExec VP:Commercial

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil